All Stories

  1. Hemodynamic and cerebral oxygenation predictors of visual darkening in pediatric POTS: a cross-sectional study
  2. Gait Analysis Using Walking-Generated Acceleration Obtained from Two Sensors Attached to the Lower Legs
  3. Case of early infant congenital bilateral axillary vein thrombosis discovered by superficial venous dilatation; a case report
  4. Clinical characteristics and management of plexiform neurofibromas in children with neurofibromatosis 1: A Japanese nationwide survey
  5. Clinical Significance of Whole-Body Computed Tomography Scans in Pediatric Out-of-Hospital Cardiac Arrest Patients Without Prehospital Return of Spontaneous Circulation
  6. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study
  7. Altered serum levels of platelet-derived growth factor receptor β and cluster of differentiation 13 suggest a role for pericytes in West syndrome
  8. Experimental and Clinical Investigation of Cytokines in Migraine: A Narrative Review
  9. Severe pediatric acute encephalopathy syndromes related to SARS-CoV-2
  10. Pediatric Cutaneous Mastocytosis With Motor and Intellectual Delay
  11. A Case of Late-Onset Group B Streptococcus Serotype Ⅰb Meningitis With Absence of Pleocytosis at the Initial Cerebrospinal Fluid Analysis
  12. Chemokine/Interleukin Imbalance Aggravates the Pathology of Respiratory Syncytial Virus Infection
  13. Involvement of Peripheral Monocytes with IL-1β in the Pathogenesis of West Syndrome
  14. Myoclonic seizures of inherited glycosylphosphatidylinositol deficiency treated with diazepam and clonazepam: a case report
  15. Correlation between Cerebrospinal Fluid IL-12 Levels and Severity of Encephalopathy in Children
  16. Role of Neuroinflammation and Blood-Brain Barrier Permutability on Migraine
  17. Experimental and Clinical Evidence of the Effectiveness of Riboflavin on Migraines
  18. The Neuroinflammatory Role of Pericytes in Epilepsy
  19. Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
  20. High mobility group box 1 and angiogenetic growth factor levels in children with central nerve system infections
  21. Epileptic encephalopathy patients with SCN2A variant initiated by neonatal seizure
  22. Links between Immune Cells from the Periphery and the Brain in the Pathogenesis of Epilepsy: A Narrative Review
  23. Interleukin-1β in peripheral monocytes is associated with seizure frequency in pediatric drug-resistant epilepsy
  24. Increased Platelet-Derived Growth Factor and Cytokine Levels in the Cerebrospinal Fluid of Patients of Sudden Unexpected Death with or without Viral Infection
  25. Complementary and Integrative Medicines as Prophylactic Agents for Pediatric Migraine: A Narrative Literature Review
  26. A study on gait measurement for detecting rotation gait
  27. Effect of scaling on muscle tension estimation using a musculoskeletal model
  28. Expression of intracellular cytokines in twins with intractable epilepsy associated with lissencephaly
  29. Cardiac Complications Caused by Respiratory Syncytial Virus Infection: Questionnaire Survey and a Literature Review
  30. Orthostatic Headache in Children Including Postural Tachycardia Syndrome and Orthostatic Hypotension: A Near-Infrared Spectroscopy Study
  31. Beta‐propeller protein–associated neurodegeneration presenting Rett‐like features: A case report and literature review
  32. A Review on the Triggers of Pediatric Migraine with the Aim of Improving Headache Education
  33. Improvement in recurrent anti-myelin oligodendrocyte glycoprotein antibody - positive cerebral cortical encephalitis not requiring anti - inflammatory therapy following the decrease in cytokine/chemokine levels
  34. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine
  35. Retrospective observation of children with the diagnosis of postural tachycardia syndrome while on atomoxetine
  36. Clinical Features and Burden Scores in Japanese Pediatric Migraines With Brainstem Aura, Hemiplegic Migraine, and Retinal Migraine
  37. Serum 25-hydroxy vitamin D levels in Japanese infants younger than 3-months old with respiratory syncytial virus infection
  38. A case of respiratory syncytial virus-associated encephalopathy in which the virus was detected in cerebrospinal fluid and intratracheal aspiration despite negative rapid test results
  39. A New Pathogenic Variant of CAKUTHED Diagnosed Based on Intellectual Disability
  40. Granzyme A Participates in the Pathogenesis of Infection-Associated Acute Encephalopathy
  41. Suspected Herpes Simplex Encephalitis with Low Copy Number DNA
  42. Poststreptococcal reactive arthritis in Japan
  43. Serial Analysis of Multiple Serum Cytokine Responses to Adrenocorticotropic Hormone Therapy in Patients With West Syndrome
  44. Spinal Fluid Cytokine Levels and Single-Photon Emission Computed Tomography Findings in Complex Febrile Seizures
  45. Sudden Unexpected Death in Epilepsy in Childhood: A Report of Two Cases
  46. Pathological analysis of children with childhood central nervous system infection based on changes in chemokines and interleukin-17 family cytokines in cerebrospinal fluid
  47. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) levels in the cerebrospinal fluid of children with influenza-associated encephalopathy
  48. High Mobility Group Box 1 in Children with Acute Encephalopathy and Other Convulsive Diseases
  49. Examination of neurological prognostic markers in patients with respiratory syncytial virus-associated encephalopathy
  50. Single-Photon Emission Computed Tomography Is an Ambiguous Imaging Method on Initial Diagnosis for Acute Encephalopathy
  51. Brain Magnetic Resonance Imaging in Acute Phase of Pandemic Influenza A (H1N1) 2009–Associated Encephalopathy in Children
  52. Brain-Derived Neurotrophic Factor and Interleukin-6 Levels in the Serum and Cerebrospinal Fluid of Children with Viral Infection-Induced Encephalopathy
  53. Severe form of encephalopathy associated with 2009 pandemic influenza A (H1N1) in Japan
  54. Effects of Indomethacin on Patent Ductus Arteriosus in Neonates with Genetic Disorders and/or Congenital Anomalies
  55. Expressions of Brain-Derived Neurotrophic Factor (BDNF) in Cerebrospinal Fluid and Plasma of Children With Meningitis and Encephalitis/Encephalopathy
  56. High production of interleukin‐10 and interferon‐γ in influenza‐associated MERS in the early phase
  57. Treatment of pandemic influenza A (H1N1) 2009-associated encephalopathy in children
  58. National survey of pandemic influenza A (H1N1) 2009‐associated encephalopathy in Japanese children
  59. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations
  60. Classification of acute encephalopathy in respiratory syncytial virus infection
  61. Cerebrospinal fluid NOx (nitrite/nitrate) in RSV-infected children with CNS symptoms